Collision cross sections obtained with ion mobility mass spectrometry as new descriptor to predict blood-brain barrier permeation by drugs.

作者: Armin Sebastian Guntner , Bernhard Thalhamer , Christian Klampfl , Wolfgang Buchberger

DOI: 10.1038/S41598-019-55856-7

关键词:

摘要: Evaluating the ability of a drug to permeate blood-brain barrier is not trivial task due structural complexity central nervous system. Nevertheless, it immense importance identify related properties drugs either be able produce desired effect in brain or avoid unwanted side effects there. In past, multiple methods have been used for that purpose. However, these are sometimes methodologically problematic and do claim universal validity. Therefore, additional new judging penetration by advantageous. Accordingly, within scope this study, we tried introduce structure-derived parameter predict permeation small molecules based on ion mobility mass spectrometry experiments – collision cross section, as an illustration branching molecular volume molecule. detail, quadrupole time-of-flight spectrometric data 46 pharmacologically active small-molecules well literature-derived permeability lipophilicity set up our model. For first time were show strong correlation between ingredients their sections.

参考文章(57)
Jeltje Boer, Ellen Ederveen, Birgitta Grundmark, Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects. Upsala Journal of Medical Sciences. ,vol. 123, pp. 174- 178 ,(2018) , 10.1080/03009734.2018.1489918
Armin Sebastian Guntner, Simon Stöcklegger, Michael Kneidinger, Udo Illievich, Wolfgang Buchberger, Development of a highly sensitive gas chromatography-mass spectrometry method preceded by solid-phase microextraction for the analysis of propofol in low-volume cerebral microdialysate samples. Journal of Separation Science. ,vol. 42, pp. 1257- 1264 ,(2019) , 10.1002/JSSC.201801066
Valérie Gabelica, Alexandre A. Shvartsburg, Carlos Afonso, Perdita Barran, Justin L.P. Benesch, Christian Bleiholder, Michael T. Bowers, Aivett Bilbao, Matthew F. Bush, J. Larry Campbell, Iain D.G. Campuzano, Tim Causon, Brian H. Clowers, Colin S. Creaser, Edwin De Pauw, Johann Far, Francisco Fernandez‐Lima, John C. Fjeldsted, Kevin Giles, Michael Groessl, Christopher J. Hogan, Stephan Hann, Hugh I. Kim, Ruwan T. Kurulugama, Jody C. May, John A. McLean, Kevin Pagel, Keith Richardson, Mark E. Ridgeway, Frédéric Rosu, Frank Sobott, Konstantinos Thalassinos, Stephen J. Valentine, Thomas Wyttenbach, Recommendations for reporting ion mobility Mass Spectrometry measurements Mass Spectrometry Reviews. ,vol. 38, pp. 291- 320 ,(2019) , 10.1002/MAS.21585
Nicholas Bodor, Peter Buchwald, Brain-Targeted Drug Delivery American Journal of Drug Delivery. ,vol. 1, pp. 13- 26 ,(2003) , 10.2165/00137696-200301010-00002
Werner J Geldenhuys, Afroz S Mohammad, Chris E Adkins, Paul R Lockman, Molecular determinants of blood–brain barrier permeation Therapeutic Delivery. ,vol. 6, pp. 961- 971 ,(2015) , 10.4155/TDE.15.32
Fionn E O'Brien, Timothy G Dinan, Brendan T Griffin, John F Cryan, Interactions between antidepressants and P-glycoprotein at the blood–brain barrier: clinical significance of in vitro and in vivo findings British Journal of Pharmacology. ,vol. 165, pp. 289- 312 ,(2012) , 10.1111/J.1476-5381.2011.01557.X
PHILIPPE AGON, PATRICK GOETHALS, DIRK HAVER, JEAN-MARC KAUFMAN, Permeability of the blood-brain barrier for atenolol studied by positron emission tomography. Journal of Pharmacy and Pharmacology. ,vol. 43, pp. 597- 600 ,(2011) , 10.1111/J.2042-7158.1991.TB03545.X
Hassan Pajouhesh, George R. Lenz, Medicinal chemical properties of successful central nervous system drugs. Neurorx. ,vol. 2, pp. 541- 553 ,(2005) , 10.1602/NEURORX.2.4.541
François Guillot, Pierrette Misslin, Michel Lemaire, Comparison of fluvastatin and lovastatin blood-brain barrier transfer using in vitro and in vivo methods. Journal of Cardiovascular Pharmacology. ,vol. 21, pp. 339- 346 ,(1993) , 10.1097/00005344-199302000-00022